Affiliation:
1. Kuban State Medical University
2. Kuban State Medical University; Regional Clinical Hospital №2
Abstract
Aim. To assess the dynamics of the main echocardiographic parameters in patients with chronic obstructive pulmonary disease (COPD) and early-stage chronic kidney disease (CKD) taking native vitamin D.Material and methods. The study included 264 patients, which were divided into two groups: experimental group (n=135) — patients with stage 2-4 COPD (men, mean age — 72,2±3,8 years, mean disease duration — 23,1±3,4 years); control group (n=136) — patients with stage 2-4 COPD, comparable in age and sex. Patients of both groups were divided into 4 subgroups depending on forced expiratory volume in 1 second and vitamin D levels. In the experimental group, native vitamin D therapy was performed according to regimen that maintains its level >34,3 ng/ml during the year; in the control group — according to the Russian Association of Endocrinologists guidelines. Echocardiography was performed for all patients at the beginning and end of the study.Results. In all subgroups of the experimental group, a statistically significant increase in the left ventricular ejection fraction was revealed (p<0,05); in patients with moderate COPD (GOLD 2) and vitamin D deficiency and patients with severe and very severe COPD (GOLD 3,4) and vitamin D insufficiency of the experimental group, we observed a significant decrease in the end-systolic dimension, average left atrial size and increase in stroke volume and stroke volume index, as well as normalization of the left ventricular geometry (p<0,05). In the control group after 12 months, no significant changes were detected.Conclusion. Maintaining of vitamin D level >34,3 ng/ml for 12 months in patients with COPD and early-stage CKD was associated with a significant improvement in myocardial remodeling. This indicates an improvement in cardiovascular adaptation and function.
Subject
Cardiology and Cardiovascular Medicine
Reference16 articles.
1. Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease. Updated 2017 Available at: http://goldcopd.org/gold-2017-global-strategy-diagnosis-management-prevention-copd.
2. Bolotova EV, Dudnikova AV. Renal dysfunction in patients with chronic obstructive pulmonary disease: comorbidity issues. Мonograph. Krasnodar: Ekoinvest, 2018; 148 р. (In Russ.) ISBN: 978-94215-402-8.
3. Onishi K. Total management of chronic obstructive pulmonary disease (COPD) as an independent risk factor for cardiovascular disease. J Cardiol. 2017;70(2):128-34. doi:10.1016/j.jjcc.201703.001.
4. Moiseev VS, Muhin NA, Muhin AV, et al. National recommendations. Cardiovascular risk and chronic kidney disease: strategies for car-dio-nephroprotection. Clinical nephrology. 2014;2:4-29. (In Russ.)
5. Hussien NI, El-Wakeel HS, Souror SM, et al. Alleviation of cardiac mitochondrial dysfunction and oxidative stress underlies the protective effect of vitamin D in chronic stress-induced cardiac dysfunction in rats. Gen Physiol Biophys. 2019;38(1):51-61. doi:10.4149/gpb_2018036.